The Enterprise Value as of June 2026 (TTM) for Cardiol Therapeutics Inc. (CRDL) is 135.78M

According to Cardiol Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 135.78M. This represents a change of 0.62% compared to the average of 134.95M of the last 4 quarters.

Cardiol Therapeutics Inc. (CRDL) Historical Enterprise Value (quarterly & annually)

How has CRDL Enterprise Value performed in the past?

The mean historical Enterprise Value of Cardiol Therapeutics Inc. over the last ten years is 61.79M. The current 135.78M Enterprise Value has changed 21.87% with respect to the historical average. Over the past ten years (40 quarters), CRDL's Enterprise Value was at its highest in in the September 2021 quarter at 196.82M. The Enterprise Value was at its lowest in in the December 2022 quarter at -15207647.16.

Cardiol Therapeutics Inc. (CRDL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cardiol Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cardiol Therapeutics Inc. (CRDL) Average Enterprise Value

How has CRDL Enterprise Value performed in the past?

The current Enterprise Value of Cardiol Therapeutics Inc. (CRDL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cardiol Therapeutics Inc. (CRDL) Enterprise Value vs. Peers

How is CRDL’s Enterprise Value compared to its peers?

Cardiol Therapeutics Inc.’s Enterprise Value is less than InterCure Ltd. (280.25M), greater than Connect Biopharma Holdings Limited (95.83M), greater than Vivani Medical, Inc. (63.51M), greater than Microbot Medical Inc. (78.36M), greater than InspireMD, Inc. (24.87M), less than Assertio Holdings, Inc. (158.33M), greater than InflaRx N.V. (85.42M), greater than Kalaris Therapeutics Inc (47.97M), greater than ImageneBio Inc (-4513289.00), greater than Hyperfine, Inc. (73.75M),

Build a custom stock screener for Cardiol Therapeutics Inc. (CRDL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cardiol Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cardiol Therapeutics Inc. (CRDL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cardiol Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.